The DOI matches its Crossref record; 123 of the 124 references it cites were found in a registry or an index.
Nicotinic–serotonergic interactions in brain and behaviour
Abstract
This review focuses on nicotinic--serotonergic interactions in the central nervous system (CNS). Nicotine increases 5-hydroxytryptamine (5-HT) release in the cortex, striatum, hippocampus, dorsal raphé nucleus (DRN), hypothalamus, and spinal cord. As yet, there is little firm evidence for nicotinic receptors on serotonergic terminals and thus nicotine's effects on 5-HT may not necessarily be directly mediated, but there is strong evidence that the 5-HT tone plays a permissive role in nicotine's effects. The effects in the cortex, hippocampus, and DRN involve stimulation of 5-HT(1A) receptors, and in the striatum, 5-HT(3) receptors. The 5-HT(1A) receptors in the DRN play a role in mediating the anxiolytic effects of nicotine and the 5-HT(1A) receptors in the dorsal hippocampus and lateral septum mediate its anxiogenic effects. The increased startle and anxiety during nicotine withdrawal is mediated by 5-HT(1A) and 5-HT(3) receptors. The locomotor stimulant effect of acute nicotine is mediated by 5-HT(1A) receptors and 5-HT(2) receptors may play a role in the expression of a sensitised response after chronic nicotine treatment. Unfortunately, the role of 5-HT(1A) receptors in mediating nicotine seeking has not yet been investigated and would seem an important area for future research. There is also evidence for nicotinic--serotonergic interactions in the acquisition of the water maze, passive avoidance, and impulsivity in the five-choice serial reaction task.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nicotine, signaling through nAChRs, can influence serotonergic transmission in a complex manner, generally acting to increase serotonin release in many brain regions (reviewed in Seth et al., 2002), including the hypothalamus (Ramos et al., 2004).”
From Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states (2015) · cites this paper as Seth et al., 2002
Citations
Cites
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400903 · Cited by 1,585
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308
A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation
Hurt, R. D., Sachs, D. P. L., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710233371703 · Cited by 1,262
Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonists
Sprouse, J. S., & Aghajanian, G. K. (1987) · Synapse · doi:10.1002/syn.890010103 · Cited by 848
Nicotinic Receptors in the Development and Modulation of CNS Synapses
Role, L. W., & Berg, D. K. (1996) · Neuron · doi:10.1016/s0896-6273(00)80134-8 · Cited by 762
Reduced antinociception in mice lacking neuronal nicotinic receptor subunits
Marubio, L. M., Jiménez, M. D. M. A., Cordero‐Erausquin, M., Léna, C., Novère, N. G. L., d’Exaerde, A. D. K., Huchet, M., Damaj, M. I., & Changeux, J. (1999) · Nature · doi:10.1038/19756 · Cited by 538
Alkondon, M., & Albuquerque, E. X. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38283-2 · Cited by 538
Decker, M. W., & McGaugh, J. L. (1991) · Synapse · doi:10.1002/syn.890070209 · Cited by 527
Bupropion is a nicotinic antagonist
Slemmer, J. E., Martin, B. R., & Damaj, M. I. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38905-0 · Cited by 509
Benwell, M. E. M., & Balfour, D. J. K. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09067.x · Cited by 426
Research works printed but not linked: 2
- Engberg, 2000, Nicotine inhibits firing activity of dorsal raphé 5-HT neurones in vivo, Naunyn-Schmiedeberg's Arch Pharmacol, 362, 41
- Ridley, 1997, The influence on nicotine on 5-HT overflow in the dorsal hippocampus of the rat, Br J Pharmacol, 122, 301P
Cited by
Sorted by citations
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 978
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 569
Addressing tobacco among individuals with a mental illness or an addiction
Williams, J. M., & Ziedonis, D. M. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.03.009 · Cited by 356
Smoking, nicotine and neuropsychiatric disorders
Döme, P., Lazáry, J., Kalapos, M. P., & Rihmer, Z. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.013 · Cited by 227
Modulators in concert for cognition: Modulator interactions in the prefrontal cortex
Briand, L. A., Gritton, H., Howe, W. M., Young, D. A., & Sarter, M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.06.007 · Cited by 216
Picciotto, M. R., Lewis, A. S., van Schalkwyk, G. I., & Mineur, Y. S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.028 · Cited by 157
Nicotine exposure during adolescence induces a depression-like state in adulthood
Iñiguez, S. D., Warren, B. L., Parise, E. M., Alcantara, L. F., Schuh, B., Maffeo, M. L., Manojlovic, Z., & Bolaños-Guzmán, C. A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.220 · Cited by 157
Levin, E. D., Lawrence, S. S., Petro, A., Horton, K., Rezvani, A. H., Seidler, F. J., & Slotkin, T. A. (2007) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2007.02.002 · Cited by 147
Zhang, L., Dong, Y., Doyon, W. M., & Dani, J. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.024 · Cited by 135
Setti-Perdigão, P., Serrano, M. A. R., Flausino, O., Bolzani, V. D. S., Guimarães, M. Z. P., & Castro, N. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082726 · Cited by 125
Neuroreceptor mechanisms of aggression and its treatment.
Swann, A. C. (2003) · PubMed · Cited by 115
Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice
Balerio, G. N., Aso, E., & Maldonado, R. J. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0251-9 · Cited by 104
Association of the Serotonin Transporter Gene With Smoking Behavior
Kremer, I., Bachner-Melman, R., Reshef, A., Broude, L., Nemanov, L., Gritsenko, I., Heresco-Levy, U., Elizur, Y., & Ebstein, R. P. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.5.924 · Cited by 101
Singer, S., Rossi, S., Verzosa, S., Hashim, A. T., Lonow, R., Cooper, T. B., Sershen, H. W., & Lajtha, Á. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000035814.45494.15 · Cited by 98
The Neuronal Pathways Mediating the Behavioral and Addictive Properties of Nicotine
Balfour, D. J. K. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-69248-5_8 · Cited by 99
Vázquez-Palacios, G., Bonilla‐Jaime, H., & Velázquez‐Moctezuma, J. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.03.002 · Cited by 89
Slotkin, T. A., Tate, C. A., Cousins, M. M., & Seidler, F. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300988 · Cited by 88
Vázquez-Palacios, G., Bonilla‐Jaime, H., & Velázquez‐Moctezuma, J. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.08.008 · Cited by 87
Garduño, J., Galindo-Charles, L., Jiménez-Rodríguez, J., Galarraga, E., Tapia, D., Mihailescu, S., & Hernandez-Lopez, S. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0941-12.2012 · Cited by 83
Jamal, M., van der Does, W. A. J., Elzinga, B. M., Molendijk, M. L., & Penninx, B. W. J. H. (2014) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntu151 · Cited by 86
Andreasen, J. T., & Redrobe, J. P. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832c713e · Cited by 82
Matteo, V. D., Pierucci, M., & Esposito, E. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02337.x · Cited by 78
Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion
Cryan, J. F., Gasparini, F., Heeke, G. V., & Markou, A. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02890-3 · Cited by 77
Management of smoking in people with psychiatric disorders
Ziedonis, D. M., & Williams, J. M. (2003) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000069086.26384.5f · Cited by 75
Villégier, A. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00223-5 · Cited by 75
GABAergic modulation of serotonergic neurons in the dorsal raphe nucleus
Hernández-Vázquez, F., Garduño, J., & Hernández‐López, S. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0014 · Cited by 72
Htoo, A. K., Talwar, A., Feinsilver, S. H., & Greenberg, H. E. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.07.003 · Cited by 76
Guillem, K., Vouillac‐Mendoza, C., Azar, M. R., Parsons, L. H., Koob, G. F., Cador, M., & Stinus, L. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05217.x · Cited by 68
Shram, M. J., Funk, D., Li, Z., & Lê, A. D. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.03.034 · Cited by 64
Tucci, S. A., Genn, R. F., & File, S. E. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(02)00391-x · Cited by 59
Galindo‐Charles, L., Hernández‐López, S., Galarraga, E., Tapia, D., Bargas, J., Garduño, J., Frías‐Dominguez, C., Drucker-Colı́n, R., & Mihailescu, S. (2008) · Synapse · doi:10.1002/syn.20526 · Cited by 58
Weiss, S., Nosten‐Bertrand, M., McIntosh, J. M., Giros, B., & Martres, M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301385 · Cited by 58
Balerio, G. N., Aso, E., & Maldonado, R. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2238-y · Cited by 54
Aboul‐Fotouh, S. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3745-5 · Cited by 53
Modulating role of serotonergic signaling in sleep and memory
Vaseghi, S., Arjmandi-Rad, S., Eskandari, M., Ebrahimnejad, M., Kholghi, G., & Zarrindast, M. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00339-8 · Cited by 52
Zaniewska, M., McCreary, A. C., Przegaliński, E., & Filip, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.067 · Cited by 46
Viveros, M., Marco, E. M., Llorente, R., & Lamota, L. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282d28fb4 · Cited by 44
Antidepressant-like action of nicotine in forced swimming test and brain serotonin in mice
Suemaru, K., YASUDA, K., Cui, R., LI, B., Umeda, K., Amano, M., MITSUHASHI, H., TAKEUCHI, N., Inoue, T., & Gomita, Y. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.05.007 · Cited by 45
Cucchiaro, G., Chaijale, N., & Commons, K. G. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079368 · Cited by 45
Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats
Levin, E. D., Slade, S. K., Johnson, M., Petro, A. E., Horton, K., Williams, P., Rezvani, A. H., & Rose, J. E. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.016 · Cited by 43
An electrophysiological endophenotype of hypomanic and hyperthymic personality
Hensch, T., Herold, U., & Brocke, B. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.11.018 · Cited by 44
Awtry, T. L., & Werling, L. L. (2003) · Synapse · doi:10.1002/syn.10259 · Cited by 41
Hayes, D. J., Mosher, T. M., & Greenshaw, A. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.08.034 · Cited by 41
Hensch, T., Wargelius, H., Herold, U., Lesch, K., Oreland, L., & Brocke, B. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301020 · Cited by 41
Cosgrove, K., Krantzler, E., Frohlich, E., Stiklus, S. M., Pittman, B. P., Tamagnan, G. D., Baldwin, R. M., Bois, F., Seibyl, J. P., Krystal, J. H., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.49 · Cited by 40
Matzel, L. D., Babiarz, J. P., Townsend, D. A., Grossman, H. C., & Grumet, M. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00382.x · Cited by 39
Schwerdtfeger, R. M. H., & Menard, J. L. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.11.011 · Cited by 39
Mechanism of action of A-85380 in an animal model of depression
Buckley, M. J., Surowy, C. S., Meyer, M., & Curzon, P. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.012 · Cited by 39
Centeno, M. L., Henderson, J. A., Pau, K. ‐. F., & Bethea, C. L. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.21026 · Cited by 38
Nicotinic excitation of serotonergic projections from dorsal raphe to the nucleus accumbens
Chang, B., Daniele, C. A., Gallagher, K., Madonia, M., Mitchum, R. D., Barrett, L. E., Vezina, P., & McGehee, D. S. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00575.2010 · Cited by 38
Cucchiaro, G., & Commons, K. G. (2003) · Synapse · doi:10.1002/syn.10218 · Cited by 37
Modulation of aggressive behavior in mice by nicotinic receptor subtypes
Lewis, A. S., Mineur, Y. S., Smith, P. H., Cahuzac, E. L. M., & Picciotto, M. R. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.019 · Cited by 37
Zaniewska, M., McCreary, A. C., & Filip, M. (2009) · Synapse · doi:10.1002/syn.20645 · Cited by 35
Batman, A. M., Munzar, P., & Beardsley, P. M. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2035-z · Cited by 35
Nicotinic–serotonergic drug interactions and attentional performance in rats
Rezvani, A. H., Caldwell, D. P., & Levin, E. D. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2060-y · Cited by 34
Association of Cigarette Smoking with Sleep Disturbance and Neurotransmitters in Cerebrospinal Fluid
Li, H., Liu, Y., Xing, L., Yang, X., Xu, J., Ren, Q., Su, K., Lu, Y., & Wang, F. (2020) · Nature and Science of Sleep · doi:10.2147/nss.s272883 · Cited by 36
Smoking and respiratory irregularity in panic disorder
Caldirola, D., Bellodi, L., Cammino, S., & Perna, G. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.013 · Cited by 33
Slotkin, T. A., & Seidler, F. J. (2006) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2006.06.001 · Cited by 33
Section I. The Cholinergic System
Smythies, J. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)64001-9 · Cited by 32
Comparison of the effects of nicotine and epibatidine on the striatal extracellular dopamine
Janhunen, S. K., & Ahtee, L. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.05.015 · Cited by 32
GABAB receptors involvement in the effects induced by nicotine on anxiety-related behaviour in mice
Varani, A. P., & Balerio, G. N. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.03.001 · Cited by 31
α7 nicotinic receptor subunit is present on serotonin neurons projecting to hippocampus and septum
Aznar, S., Kostova, V., Christiansen, S. H., & Knudsen, G. M. (2005) · Synapse · doi:10.1002/syn.20108 · Cited by 31
Nicotine dependence – human and animal studies, current pharmacotherapies and future perspectives
Zaniewska, M., Przegaliński, E., & Filip, M. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70157-4 · Cited by 30
Ma, Z., Strecker, R. E., McKenna, J. T., Thakkar, M. M., McCarley, R. W., & Tao, R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.074 · Cited by 28
Semba, J., & Wakuta, M. (2008) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2008.01822.x · Cited by 28
Gulick, D., & Gould, T. J. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00209.x · Cited by 26
Quaak, M., van Schayck, O. C. P., Postma, D. S., Wagena, E. J., & van Schooten, F. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03534.x · Cited by 26
Koudsi, N. A., & Tyndale, R. F. (2005) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000179842.63515.c6 · Cited by 25
Bloch, B., Reshef, A., Cohen, T. R., Tafla, A., Gathas, S., Israel, S., Gritsenko, I., Kremer, I., & Ebstein, R. P. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.12.015 · Cited by 26
Smith, T. C., LeardMann, C. A., Smith, B., Jacobson, I. G., Miller, S. C., Wells, T. S., Boyko, E. J., & Ryan, M. A. K. (2014) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000050 · Cited by 25
Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits
Vieira‐Brock, P. L., McFadden, L. M., Nielsen, S. M., Smith, M. D., Hanson, G. R., & Fleckenstein, A. E. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv073 · Cited by 25
Zhilyakov, N., Arkhipov, A., Malomouzh, A., & Samigullin, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169031 · Cited by 19
Han, J., Wang, D.-S., Liu, S.-B., & Zhao, M. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2015.113 · Cited by 24
Lewis, A. S., & Picciotto, M. R. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107929 · Cited by 23
García‐González, J., Brock, A. J., Parker, M. O., Riley, R. J., Joliffe, D., Sudwarts, A., Teh, M., Busch‐Nentwich, E. M., Stemple, D. L., Martineau, A. R., et al. (2020) · eLife · doi:10.7554/elife.51295 · Cited by 23
Besson, M., Guiducci, S., Granon, S., Guilloux, J., Guiard, B. P., Repérant, C., Fauré, P., Pons, S., Cannazza, G., Zoli, M., et al. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4362-2 · Cited by 27
The effects of nicotine on nitric oxide induced anxiogenic-like behaviors in the dorsal hippocampus
Piri, M., Nasehi, M. M., Shahab, Z., & Zarrindast, M. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.08.074 · Cited by 22
Regional Heterogeneity of Nicotine Effects on Neurotransmitters in Rat Brains in vivo at Low Doses
Rossi, S., Singer, S., Shearman, E., Sershen, H. W., & Lajtha, Á. (2005) · Neurochemical Research · doi:10.1007/s11064-004-9690-7 · Cited by 22
Decreased platelet vesicular monoamine transporter density in habitual smokers
Schwartz, K., Weizman, A., & Rehavi, M. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.11.001 · Cited by 22
Bhatti, A. S., Aydin, C., Oztan, O., Ma, Z., Hall, P., Tao, R., & Isgor, C. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1366-6 · Cited by 21
Hansen, C. P., Jensen, A. A., Christensen, J. K., Balle, T., Liljefors, T., & Frølund, B. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701625v · Cited by 21
Funktionelle Neuroanatomie des limbischen Systems
Roth, G., & Dicke, U. (2006) · Springer eBooks · doi:10.1007/3-540-30887-3_1 · Cited by 22
Why are Antidepressant Drugs Effective Smoking Cessation Aids?
Shoaib, M. C., & Buhidma, Y. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170915142122 · Cited by 22
Hayase, T. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-20 · Cited by 20
Effects of transdermal nicotine delivery on cognitive outcomes: A meta‐analysis
Majdi, A., Sadigh‐Eteghad, S., & GJEDDE, A. H. (2021) · Acta Neurologica Scandinavica · doi:10.1111/ane.13436 · Cited by 19
Tirgar, F., Rezayof, A., & Zarrindast, M. R. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.07.014 · Cited by 19
Rasmussen, H. B., Bagger, Y. Z., Tankó, L. B., Christiansen, C., & Werge, T. M. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30880 · Cited by 19
Chung, C.-M., Kuo, T.-M., Chiang, S.-L., Wang, Z.-H., Hung, C.-C., Lane, H.-Y., Liu, C.-S., & Ko, Y.-C. (2016) · Oncotarget · doi:10.18632/oncotarget.7049 · Cited by 19
Awtry, T. L., Frank, J. G., & Werling, L. L. (2006) · Synapse · doi:10.1002/syn.20251 · Cited by 19
Jawinski, P., Mauche, N., Ulke, C., Huang, J., Spada, J., Enzenbach, C., Sander, C., Hegerl, U., & Hensch, T. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4268-z · Cited by 16
Alternative Interacting Sites and Novel Receptors for Cannabinoid Ligands
Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_9 · Cited by 17
Muñoz-Castañeda, R., Díaz, D., Ávila-Zarza, C. A., Alonso, J. R., & Weruaga, E. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3284-5 · Cited by 16
Vázquez-Palacios, G., González, M. H., Guevara, M. Á., & Bonilla‐Jaime, H. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.11.004 · Cited by 18
Patkar, A. A., Gopalakrishnan, R., Berrettini, W. H., Weinstein, S. P., Vergare, M. J., & Leone, F. T. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1353-2 · Cited by 16
O'Connor, S. M., Sleebs, B. E., Street, I. P., Flynn, B. L., Baell, J. B., Coles, C., Quazi, N., Paul, D., Poiraud, E., Huyard, B., et al. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109836 · Cited by 15
Varani, A. P., Pedrón, V. T., Bettler, B., & Balerio, G. N. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.030 · Cited by 15
Lau, W. K., Cui, L. Y., Chan, S. C. H., Ip, M., & Mak, J. (2016) · Free Radical Research · doi:10.3109/10715762.2016.1145355 · Cited by 15
Wang, T., Moon, J., Wu, Y., Amos, C. I., Hung, R. J., Tardón, A., Andrew, A. S., Chen, C., Christiani, D. C., Albanes, D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185660 · Cited by 17
Serotonin Interaction with Other Transmitter Systems
Adell, A., Bortolozzi, A. A., Díaz-Mataix, L., Santana, N., Celada, P., & Artigas, F. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70083-7 · Cited by 15
Effect of 5-HT in mianserin-pretreated rats on the structure of feeding behavior
Díaz, J. M. M. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00059-7 · Cited by 14
Metadata
- Authors
- Seth, P., Cheeta, S., Tucci, S., & File, S. E.
- Affiliations
- King's College London (GB)
- Corresponding author
- File, Sandra E.
- ORCID
- Cheeta, Survjit
- Venue
- Pharmacology Biochemistry and Behavior
- Publisher
- Elsevier BV
- Published
- 2002-04
- Volume
- 71
- Issue
- 4
- Pages
- 795-805
- ISSN
- 0091-3057 (ISSN-L)
- OpenAlex
- W2033178939
- Cited by
- 145
- References
- 124
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 6 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 8 · 2015: 3 · 2014: 7 · 2013: 8 · 2012: 5
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacology Biochemistry and Behavior (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotine, serotonin, 5-HT1A receptor, 5-HT3 receptor, 5-HT2 receptor, dorsal raphe nucleus, dorsal hippocampus, striatum, anxiolytic effects, anxiogenic effects, nicotine withdrawal, startle response, locomotor stimulant effects, sensitization, nicotine seeking, impulsivity, water maze, passive avoidance
- MeSH terms
- Central Nervous System Stimulants, Animals, Anxiety, Behavior, Behavior, Animal, Brain, Humans, Synaptic Transmission, Receptors, Nicotinic, Receptors, Serotonin, Reward
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review